Rating History for SAB Biotherapeutics (SABS) by UBS

More Stocks Rated by UBS | Latest Ratings for SABS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/7/2026 Michael Yee New Coverage Buy
(N/A)		 7.00
(N/A)		 3.74
(3.79)		 1.34% Details